Literature DB >> 17164456

Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events.

Leslie A Lange1, Christopher S Carlson, Lucia A Hindorff, Ethan M Lange, Jeremy Walston, J Peter Durda, Mary Cushman, Joshua C Bis, Donglin Zeng, Danyu Lin, Lewis H Kuller, Deborah A Nickerson, Bruce M Psaty, Russell P Tracy, Alexander P Reiner.   

Abstract

CONTEXT: C-reactive protein (CRP) is an inflammation protein that may play a role in the pathogenesis of cardiovascular disease (CVD).
OBJECTIVE: To assess whether polymorphisms in the CRP gene are associated with plasma CRP, carotid intima-media thickness (CIMT), and CVD events. DESIGN, SETTING, AND PARTICIPANTS: In the prospective, population-based Cardiovascular Health Study, 4 tag single-nucleotide polymorphisms (SNPs) (1919A/T, 2667G/C, 3872G/A, 5237A/G) were genotyped in 3941 white (European American) participants and 5 tag SNPs (addition of 790A/T) were genotyped in 700 black (African American) participants, aged 65 years or older, all of whom were without myocardial infarction (MI) or stroke before study entry. Median follow-up was 13 years (1989-2003). MAIN OUTCOME MEASURES: Baseline CIMT; occurrence of MI, stroke, and CVD mortality during follow-up.
RESULTS: In white participants, 461 incident MIs, 491 incident strokes, and 490 CVD-related deaths occurred; in black participants, 67 incident MIs, 78 incident strokes, and 75 CVD-related deaths occurred. The 1919T and 790T alleles were associated with higher CRP levels in white and black participants, respectively. The 3872A allele was associated with lower CRP levels in both populations, and the 2667C allele was associated with lower CRP levels in white participants only. There was no association between CIMT and any CRP gene polymorphism in either population. In white participants, the 1919T allele was associated with increased risk of stroke for TT vs AA (hazard ratio [HR], 1.40; 95% confidence interval [CI], 1.06-1.87) and for CVD mortality (HR, 1.40; 95% CI, 1.10-1.90). In black participants, homozygosity for the 790T allele was associated with a 4-fold increased risk of MI compared with homozygosity for the 790A allele (95% CI, 1.58-10.53). The minor alleles of the 2 SNPs associated with lower plasma CRP concentration in white participants (2667C and 3872A) were associated with decreased risk of CVD mortality.
CONCLUSIONS: Genetic variation in the CRP gene is associated with plasma CRP levels and CVD risk in older adults.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17164456     DOI: 10.1001/jama.296.22.2703

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  90 in total

1.  Biogeographic ancestry, self-identified race, and admixture-phenotype associations in the Heart SCORE Study.

Authors:  Indrani Halder; Kevin E Kip; Suresh R Mulukutla; Aryan N Aiyer; Oscar C Marroquin; Gordon S Huggins; Steven E Reis
Journal:  Am J Epidemiol       Date:  2012-07-06       Impact factor: 4.897

2.  Common variants in the CRP gene in relation to longevity and cause-specific mortality in older adults: the Cardiovascular Health Study.

Authors:  Lucia A Hindorff; Kenneth M Rice; Leslie A Lange; Paula Diehr; Indrani Halder; Jeremy Walston; Pui Kwok; Elad Ziv; Caroline Nievergelt; Steven R Cummings; Anne B Newman; Russell P Tracy; Bruce M Psaty; Alexander P Reiner
Journal:  Atherosclerosis       Date:  2007-09-21       Impact factor: 5.162

Review 3.  Inflammatory markers and stroke.

Authors:  Mitchell S V Elkind
Journal:  Curr Cardiol Rep       Date:  2009-01       Impact factor: 2.931

4.  Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations.

Authors:  W H Linda Kao; Dan E Arking; Wendy Post; Thomas D Rea; Nona Sotoodehnia; Ronald J Prineas; Bryan Bishe; Betty Q Doan; Eric Boerwinkle; Bruce M Psaty; Gordon F Tomaselli; Josef Coresh; David S Siscovick; Eduardo Marbán; Peter M Spooner; Gregory L Burke; Aravinda Chakravarti
Journal:  Circulation       Date:  2009-02-09       Impact factor: 29.690

5.  C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older.

Authors:  Brandon L Pierce; Mary L Biggs; Marvalyn DeCambre; Alexander P Reiner; Christopher Li; Annette Fitzpatrick; Christopher S Carlson; Janet L Stanford; Melissa A Austin
Journal:  Cancer Causes Control       Date:  2009-03-08       Impact factor: 2.506

6.  Epidemiology, heritability, and genetic linkage of C-reactive protein in African Americans (from the Jackson Heart Study).

Authors:  Ervin R Fox; Emelia J Benjamin; Daniel F Sarpong; Charles N Rotimi; James G Wilson; Michael W Steffes; Guanjie Chen; Adebowale Adeyemo; Jason K Taylor; Tandaw E Samdarshi; Herman A Taylor
Journal:  Am J Cardiol       Date:  2008-07-25       Impact factor: 2.778

7.  Genetics of C-reactive protein and complement factor H have an epistatic effect on carotid artery compliance: the Cardiovascular Risk in Young Finns Study.

Authors:  J Jylhävä; C Eklund; T Pessi; O T Raitakari; M Juonala; M Kähönen; J S A Viikari; T Lehtimäki; M Hurme
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

Review 8.  Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agents.

Authors:  Jian Shen; Jose M Ordovas
Journal:  Clin Chem       Date:  2008-12-12       Impact factor: 8.327

9.  Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke.

Authors:  Joshua C Bis; Susan R Heckbert; Nicholas L Smith; Alexander P Reiner; Kenneth Rice; Thomas Lumley; Lucia A Hindorff; Kristin D Marciante; Daniel A Enquobahrie; Stephanie A Monks; Bruce M Psaty
Journal:  Atherosclerosis       Date:  2007-11-05       Impact factor: 5.162

10.  CRP polymorphisms and progression of chronic kidney disease in African Americans.

Authors:  Adriana M Hung; Dana C Crawford; Marie R Griffin; Kristin Brown-Gentry; Michael S Lipkowitz; Edward D Siew; Kerri Cavanaugh; Julia B Lewis; T Alp Ikizler
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.